Industry Strength Score
16/100
Composite price performance score based on 3, 6, and 12-month returns, with more weight on recent trends.
EMBECTA CORP (EMBC) Stock Price & Overview
NASDAQ:EMBC • US29082K1051
Current stock price
8.86 USD
-0.17 (-1.88%)
Last:
The current stock price of EMBC is 8.86 USD. Today EMBC is down by -1.88%. In the past month the price increased by 2.15%. In the past year, price decreased by -29.07%.
EMBC Key Statistics
52-Week Range8.47 - 15.55
Current EMBC stock price positioned within its 52-week range.
1-Month Range8.51 - 9.9
Current EMBC stock price positioned within its 1-month range.
- Market Cap
- 524.689M
- P/E
- 2.92
- Fwd P/E
- 3.02
- EPS (TTM)
- 3.03
- Dividend Yield
- 6.56%
EMBC Stock Performance
Today
-1.88%
1 Week
-1.10%
1 Month
+2.15%
3 Months
-14.89%
Longer-term
6 Months -32.31%
1 Year -29.07%
2 Years -10.86%
3 Years -67.46%
5 Years N/A
10 Years N/A
EMBC Stock Chart
EMBC Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to EMBC. When comparing the yearly performance of all stocks, EMBC is a bad performer in the overall market: 86.85% of all stocks are doing better.
Chartmill TA Rating
Chartmill Setup Rating
EMBC Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to EMBC. EMBC scores excellent on profitability, but there are some minor concerns on its financial health.
Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
EMBC Earnings
On February 5, 2026 EMBC reported an EPS of 0.71 and a revenue of 261.20M. The company beat EPS expectations (3.89% surprise) and missed revenue expectations (-0.76% surprise).
Next Earnings DateMay 5, 2026
Last Earnings DateFeb 5, 2026
PeriodQ1 / 2026
EPS Reported$0.71
Revenue Reported261.2M
EPS Surprise 3.89%
Revenue Surprise -0.76%
EMBC Forecast & Estimates
9 analysts have analysed EMBC and the average price target is 17 USD. This implies a price increase of 91.87% is expected in the next year compared to the current price of 8.86.
For the next year, analysts expect an EPS growth of -3.32% and a revenue growth -1% for EMBC
Analysts
Analysts51.11
Price Target17 (91.87%)
EPS Next Y-3.32%
Revenue Next Year-1%
EMBC Index Membership
EMBC is currently included in the following stock indexes tracked on ChartMill.
EMBC Financial Highlights
Over the last trailing twelve months EMBC reported a non-GAAP Earnings per Share(EPS) of 3.03. The EPS increased by 20.72% compared to the year before.
Income Statements
Revenue(TTM)1.08B
Net Income(TTM)139.50M
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 12.92% | ||
| ROA | 13.11% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
Chartmill High Growth Momentum
EPS Q2Q%9.23%
Sales Q2Q%-0.27%
EPS 1Y (TTM)20.72%
Revenue 1Y (TTM)-2.53%
EMBC Ownership
Ownership
Inst Owners101.57%
Shares59.22M
Float58.22M
Ins Owners1.52%
Short Float %9.96%
Short Ratio7.03
EMBC Industry Overview
EMBC operates in the Health Care Supplies sub-industry within the Health Care sector. This group contains 34 stocks and is scored by ChartMill on both price strength and growth momentum.
Industry Growth Score
33/100
Composite growth score based on earnings growth, revenue growth, and profitability across the sub-industry.
Relative Performance
Each rank shows how many other sub-industries were outperformed over that timeframe.
1 Month Rank
22%
Outperformed 22% of sub-industries
3 Month Rank
14%
Outperformed 14% of sub-industries
6 Month Rank
25%
Outperformed 25% of sub-industries
Industry Fundamentals & Breadth
- Members
- 34
- New Highs
- 2.9%
- New Lows
- 8.8%
- Average ROE
- 12.6%
- Average Profit Margin
- 7.9%
- Average Operating Margin
- 10.8%
- Average P/E
- 24.6
- Average Fwd P/E
- 21.6
- Average Debt/Equity
- 0.9
EMBC Competitors/Peers
The largest stocks on the US markets in the "Health Care Supplies" sub-industry
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| MDLN | MEDLINE INC-CL A | 29.05 | 58.118B | ||
| ALGN | ALIGN TECHNOLOGY INC | 15.45 | 12.697B | ||
| COO | COOPER COS INC/THE | 12.22 | 12.31B | ||
| SOLV | SOLVENTUM CORP | 10.13 | 11.707B | ||
| LNTH | LANTHEUS HOLDINGS INC | 15.33 | 5.428B | ||
| MMSI | MERIT MEDICAL SYSTEMS INC | 15.62 | 3.981B | ||
| ICUI | ICU MEDICAL INC | 14.15 | 3.024B | ||
| HAE | HAEMONETICS CORP/MASS | 11.13 | 2.781B | ||
| XRAY | DENTSPLY SIRONA INC | 7.84 | 2.353B | ||
| NEOG | NEOGEN CORP | 26.95 | 2.033B | ||
| UFPT | UFP TECHNOLOGIES INC | 19.25 | 1.505B | ||
| STAA | STAAR SURGICAL CO | N/A | 1.322B | ||
| AVNS | AVANOS MEDICAL INC | 24.12 | 1.146B |
Related stock screener links
View all stocks in the Health Care Supplies Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About EMBC
Company Profile
Embecta Corp. engages in the provision of medical devices used in the treatment of diabetes. The company is headquartered in Parsippany, New Jersey and currently employs 1,850 full-time employees. The company went IPO on 2022-03-21. The firm has a portfolio of marketed products, including a variety of pen needles, syringes and safety injection devices. Its pen needles are sterile, single-use, medical devices, designed to be used in conjunction with pen injectors that inject insulin or other diabetes medications. The company also sells safety pen needles, which have shields on both ends of the cannula that automatically deploy after the injection to help prevent needlestick exposure and injury during injection and disposal. Its traditional and safety pen needles are compatible and frequently used with pen injectors in the market. The company sells sterile, single-use insulin syringes, which are used to inject insulin drawn from insulin vials. The company also sells safety insulin syringes. The company distributes its products through a variety of channels, including retail, hospitals and pharmacies.
Company Info
IPO: 2022-03-21
EMBECTA CORP
300 Kimball Drive, Suite 300
Parsippany NEW JERSEY US
Employees: 1850
Phone: 18624010000
EMBECTA CORP / EMBC FAQ
What does EMBC do?
Embecta Corp. engages in the provision of medical devices used in the treatment of diabetes. The company is headquartered in Parsippany, New Jersey and currently employs 1,850 full-time employees. The company went IPO on 2022-03-21. The firm has a portfolio of marketed products, including a variety of pen needles, syringes and safety injection devices. Its pen needles are sterile, single-use, medical devices, designed to be used in conjunction with pen injectors that inject insulin or other diabetes medications. The company also sells safety pen needles, which have shields on both ends of the cannula that automatically deploy after the injection to help prevent needlestick exposure and injury during injection and disposal. Its traditional and safety pen needles are compatible and frequently used with pen injectors in the market. The company sells sterile, single-use insulin syringes, which are used to inject insulin drawn from insulin vials. The company also sells safety insulin syringes. The company distributes its products through a variety of channels, including retail, hospitals and pharmacies.
What is the current price of EMBC stock?
The current stock price of EMBC is 8.86 USD. The price decreased by -1.88% in the last trading session.
Does EMBECTA CORP pay dividends?
EMBECTA CORP (EMBC) has a dividend yield of 6.56%. The yearly dividend amount is currently 0.6.
What is the ChartMill rating of EMBECTA CORP stock?
EMBC has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
Can you provide the upcoming dividend date for EMBECTA CORP?
The next ex-dividend date for EMBECTA CORP (EMBC) is February 27, 2026.
What is the employee count for EMBC stock?
EMBECTA CORP (EMBC) currently has 1850 employees.
When does EMBECTA CORP (EMBC) report earnings?
EMBECTA CORP (EMBC) will report earnings on 2026-05-05.